Changes of Bone Mineral Density in Total Hip Arthroplasty
1 other identifier
observational
117
0 countries
N/A
Brief Summary
The study was performed as a prospective, single center study at the Department of Orthopedics, Sacred Heart of Jesus Hospital Vienna, Austria. 117 patients were enrolled in a from January 2016 to May 2017. 53 patients received an isoelastic monoblock cup (RM Pressfit vitamys® Mathys) and 64 patients received a metal- backed modular cup (ANA.NOVA® ImplanTec). Dual-energy x-ray absorptiometry scans according to DeLee and Charnley Zones were performed at time points 0, 3, 6, 12, and 24 months after surgery. The aim of thise study was to compare changes in BMD between an isoelastic monoblock cup and a titanium modular cup. We hypothesized that the more elastic monoblock cup performs better than the more rigid modular cup with regard to changes in BMD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2016
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 9, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
July 10, 2021
CompletedFirst Posted
Study publicly available on registry
July 15, 2021
CompletedJuly 15, 2021
July 1, 2021
3.4 years
July 10, 2021
July 10, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dexa meassurments
Changes in BMD according to DeLee and Charnley Zones
24 Months
Study Arms (2)
Monoblock Cup
53 patients received a monoblock cup (RM Pressfit vitamys®)
Modular Cup
64 patients received a modular cup (ANA.NOVA® Implantec)
Eligibility Criteria
Patients who either received a monoblock cup (RM Pressfit vitamys®; Mathys Ltd. Bettlach, Switzerland), or a titanium shell (ANA.NOVA® Implantec, Mödling, Austria) between January 2016 and May 2017. 117 patients (female 69, male 48), mean age was 68 years (range, 43 to 89 years)
You may qualify if:
- any patient aged from 18 years onwards undergoing primary cementless THA for degenerative joint disease, including osteoarthritis, post-traumatic arthritis, congenital hip dysplasia and avascular necrosis.
You may not qualify if:
- patients with malignant diseases and pregnant women, additionally, patients were excluded if severe complications such as fracture or revision surgery occurred during the study period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. med. univ
Study Record Dates
First Submitted
July 10, 2021
First Posted
July 15, 2021
Study Start
January 1, 2016
Primary Completion
May 9, 2019
Study Completion
April 1, 2021
Last Updated
July 15, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share